ADMA Biologics Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/29/2026

1. LFTO
2. CMCSA
3. QNT
4. NVDA
5. VRDN
6. INIO
7. HONA
8. ABBV
9. HON
10. SPY

Go back to ADMA Biologics Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

ADMA Biologics (ADMA) Tops Q4 EPS by 31c, Offers Guidance

March 3, 2025 4:20 PM EST

ADMA Biologics (NASDAQ: ADMA) reported Q4 EPS of $0.46, $0.31 better than the analyst estimate of $0.15. Revenue for the quarter came in at $117.5 million versus the consensus estimate of $113.4 million.

GUIDANCE:

ADMA Biologics sees FY2025 revenue of $490 million.

ADMA Biologics sees FY2026... More